First CRISPR trial in humans will attempt to battle lung cancer

7/26/2016

This article discusses the first human trial involving the gene-editing technology known as CRISPR-Cas9. The trial, conducted in China, aimed to test the effectiveness of using CRISPR to edit the DNA of immune cells to target and eliminate cancer cells in lung cancer patients. The article explains the process and potential implications of CRISPR gene editing, highlighting both the excitement and ethical concerns surrounding this groundbreaking technology. The trial results, although preliminary, showed promise in terms of safety and potential efficacy. This trial marks an important milestone in the development and application of CRISPR technology in human medicine.

gene editing ꞏ crispr ꞏ genetic engineering ꞏ biotechnology ꞏ medical research ꞏ cancer treatment ꞏ gene therapy ꞏ clinical trials ꞏ precision medicine ꞏ genetic modification ꞏ genetic diseases ꞏ gene sequencing ꞏ molecular biology ꞏ dna editing ꞏ genetic technology ꞏ healthcare ꞏ genetic mutations ꞏ genetic disorders ꞏ chinese research ꞏ scientific breakthrough ꞏ genetic medicine ꞏ genomic medicine ꞏ ethical implications ꞏ biomedical ethics ꞏ genetic manipulation ꞏ genetic revolution ꞏ personalized medicine ꞏ genetic advancements ꞏ genetic testing ꞏ genetics research ꞏ therapeutic applications ꞏ gene-based therapies ꞏ experimental treatments